Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.

NCT04710732 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Lack of the eligible patients

Conditions

Venous Thromboembolism

Interventions

DRUG: Standard Enoxaparin 40 mg once-daily before randomization
DRUG: Standard Enoxaparin 40 mg once-daily after randomization
DRUG: Escalated Enoxaparin 30 mg twice-daily after randomization
DEVICE: Anti-embolic elastic compression stockings
DIAGNOSTIC_TEST: Thrombodynamic test (TD)

Sponsor

Pirogov Russian National Research Medical University